Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,750.00    -24.00 (-1.35%)
Bid:
1,748.00
Ask:
1,751.00
Spread: 3.00 (0.172%)
Market Cap: £3.44b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Year End Trading Update

28 Aug 2025 07:00

RNS Number : 9365W
Softcat PLC
28 August 2025
 

28 August 2025

Softcat plc

Year End Trading Update

 

Softcat plc ("Softcat", or the "Group"), a leading UK provider of IT infrastructure technology and services, today publishes a trading update (unaudited) for the financial year ended 31 July 2025.

 

Following the update provided on 28 May, the Group continued to trade well during the fourth quarter, supported by further conversion of larger solutions projects. As a result, the Board now expects to deliver high-teens growth in full year gross profit and mid-teens growth in operating profit1. The Group also remains highly cash generative, with FY2025 cash conversion2 expected to be towards the top end of our guided range of 85%-95%.

 

Looking ahead, Softcat remains well positioned to deliver further growth. Excluding the significant incremental contribution from large projects in FY2025, the Board expects to deliver low double-digit gross profit growth and high single-digit operating profit growth in FY20263. Including the significant incremental contribution from large deals in the comparative period, this translates to reported rates of high single-digit gross profit growth and low single-digit growth in operating profit.

 

Softcat's FY2025 preliminary results are scheduled for release on 22 October 2025.

 

 

1 Full year operating profit adjusted to remove non-underlying items, including acquisition-related expenses such as the fair value of deferred contingent consideration, and implementation costs of the new sales system. FY2025 guidance remains on a consistent basis with that provided in previous statements.

2 Cash conversion adjusted to remove the impact of non-underlying items and acquisition-related cash flows.

3Operating profit excluding the significant incremental contribution from large deals in FY2025 is c.£170m.

 

For further information, please contact:

Softcat plc

Graham Charlton, Chief Executive Officer + 44 (0)1628 403 610

Katy Mecklenburgh, Chief Financial Officer

Michael Watts, Head of Investor Relations

 

Media Enquiries ‐ FTI Consulting LLP

Ed Bridges/Matt Dixon + 44 (0)20 3727 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLRTSIDFIE
Date   Source Headline
20th Jan 20259:34 amRNSHolding(s) in Company
17th Jan 20253:51 pmRNSDirector/PDMR Shareholding
8th Jan 20252:02 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:52 amRNSTotal Voting Rights
12th Dec 20243:07 pmRNSDirector/PDMR Shareholding
10th Dec 20243:40 pmRNSDirector/PDMR Shareholding
10th Dec 202412:54 pmRNSResult of AGM
4th Dec 20242:22 pmRNSDirector/PDMR Shareholding
2nd Dec 202412:11 pmRNSTotal Voting Rights
26th Nov 202410:47 amRNSDirector/PDMR Shareholding
26th Nov 202410:45 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSQ1 2025 Trading Update
18th Nov 20241:55 pmRNSBlock listing Interim Review
11th Nov 20243:31 pmRNSDirector/PDMR Shareholding
1st Nov 20242:36 pmRNSAnnual Financial Report
1st Nov 20249:19 amRNSTotal Voting Rights
24th Oct 20247:00 amRNSFinal Results
14th Oct 202410:01 amRNSHolding(s) in Company
8th Oct 20243:06 pmRNSDirector/PDMR Shareholding
7th Oct 20242:28 pmRNSNotice of Results
1st Oct 20242:37 pmRNSTotal Voting Rights
26th Sep 20249:34 amRNSHolding(s) in Company
16th Sep 20249:41 amRNSHolding(s) in Company
13th Sep 202410:21 amRNSHolding(s) in Company
11th Sep 20249:26 amRNSDirector/PDMR Shareholding
22nd Aug 20249:30 amRNSHolding(s) in Company
9th Aug 202410:45 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSTotal Voting Rights
24th Jul 20249:32 amRNSHolding(s) in Company
9th Jul 202412:29 pmRNSDirector/PDMR Shareholding
1st Jul 20249:17 amRNSTotal Voting Rights
10th Jun 202412:53 pmRNSChange of Adviser
10th Jun 202411:24 amRNSDirector/PDMR Shareholding
3rd Jun 20249:26 amRNSTotal Voting Rights
28th May 20247:00 amRNSQ3 2024 Trading Update
23rd May 202410:02 amRNSBlock listing Interim Review
10th May 20242:25 pmRNSDirector/PDMR Shareholding
9th May 20243:09 pmRNSDirector/PDMR Shareholding
1st May 202410:50 amRNSTotal Voting Rights
9th Apr 20249:45 amRNSDirector/PDMR Shareholding
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20241:00 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSHalf-year Report
15th Mar 20242:45 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSNotice of Results
1st Mar 20242:28 pmRNSHolding(s) in Company
1st Mar 202410:47 amRNSTotal Voting Rights
8th Feb 20249:34 amRNSDirector/PDMR Shareholding
1st Feb 20249:49 amRNSTotal Voting Rights
30th Jan 20249:58 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.